MX2011013385A - Metodos para cultivar celulas madre y celulas progenitoras. - Google Patents

Metodos para cultivar celulas madre y celulas progenitoras.

Info

Publication number
MX2011013385A
MX2011013385A MX2011013385A MX2011013385A MX2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A
Authority
MX
Mexico
Prior art keywords
methods
progenitor cells
cells
culturing stem
stem
Prior art date
Application number
MX2011013385A
Other languages
English (en)
Inventor
Cynthia Bamdam
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of MX2011013385A publication Critical patent/MX2011013385A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16Enzymes or microbial cells immobilised on or in a biological cell
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • C12N5/0695Stem cells; Progenitor cells; Precursor cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/30Coculture with; Conditioned medium produced by tumour cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/90Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)

Abstract

La presente solicitud describe un método para cultivar, expandir o desarrollar células madre o tipo madre o células madre pluripotentes inducidas sobre una superficie, que incluye adherir las células a la superficie a través de un ligando que se une a la superficie y las células.
MX2011013385A 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras. MX2011013385A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18631009P 2009-06-11 2009-06-11
US32377910P 2010-04-13 2010-04-13
PCT/US2010/038438 WO2010144887A1 (en) 2009-06-11 2010-06-11 Methods for culturing stem and progenitor cells

Publications (1)

Publication Number Publication Date
MX2011013385A true MX2011013385A (es) 2012-05-29

Family

ID=43306642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013385A MX2011013385A (es) 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras.

Country Status (15)

Country Link
US (3) US8535944B2 (es)
EP (3) EP2440652B1 (es)
JP (1) JP2012529890A (es)
KR (4) KR20120025601A (es)
CN (2) CN102549146B (es)
AU (2) AU2010259858A1 (es)
BR (1) BRPI1011127A2 (es)
CA (1) CA2767164C (es)
DO (1) DOP2011000384A (es)
EA (1) EA026732B1 (es)
IL (1) IL216902B (es)
MX (1) MX2011013385A (es)
MY (1) MY157524A (es)
SG (1) SG176801A1 (es)
WO (1) WO2010144887A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516383A (ja) 2002-09-09 2006-07-06 デイナ−ファーバー キャンサー インスティチュート,インコーポレイテッド Bh3ペプチドおよびその使用方法
US8221966B2 (en) 2006-03-31 2012-07-17 Dana Farber Cancer Institute Methods of determining cellular chemosensitivity
US20090075926A1 (en) * 2006-12-06 2009-03-19 Bamdad Cynthia C Method for identifying and manipulating cells
EP4201421A1 (en) * 2008-10-09 2023-06-28 Minerva Biotechnologies Corporation Method for inducing pluripotency in cells
DK3633025T3 (da) 2009-11-12 2022-12-12 Technion Res & Dev Foundation Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
US10485829B2 (en) 2009-11-17 2019-11-26 Astellas Institute For Regenerative Medicine Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
WO2011159960A2 (en) * 2010-06-16 2011-12-22 Minerva Biotechnologies Corporation Reprogramming cancer cells
WO2012126013A2 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
JP2014517690A (ja) * 2011-05-09 2014-07-24 ミネルバ バイオテクノロジーズ コーポレーション 遺伝子操作した成長因子変異体
AU2012253366A1 (en) * 2011-05-11 2014-01-09 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
CA2852244C (en) 2011-10-17 2023-10-17 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
WO2014012115A2 (en) * 2012-07-13 2014-01-16 Minerva Biotechnologies Corporation Method for inducing cells to less mature state
CN111849874A (zh) * 2012-07-24 2020-10-30 米纳瓦生物技术公司 Nme变体物种表达和抑制
EP2885000A4 (en) * 2012-08-14 2015-12-23 Minerva Biotechnologies Corp STEM CELL IMPROVING THERAPEUTICS
CA2885230C (en) 2012-09-19 2021-08-03 Anthony Letai Dynamic bh3 profiling
KR20140073215A (ko) * 2012-12-06 2014-06-16 삼성전자주식회사 세포 분리용 조성물, 키트 및 이를 이용한 세포 분리 방법
WO2014130741A2 (en) * 2013-02-20 2014-08-28 Minerva Biotechnologies Corporation Nme inhibitors and methods of using nme inhibitors
WO2015035996A1 (en) * 2013-09-11 2015-03-19 Amphidex A/S Cell culture products for adherent cell cultures and manufacture thereof
EP3047276B1 (en) 2013-09-19 2023-06-14 Dana-Farber Cancer Institute, Inc. Methods of bh3 profiling
WO2015157322A2 (en) 2014-04-07 2015-10-15 Minerva Biotechnologies Corporation Anti-nme antibody
US10596492B2 (en) 2014-07-09 2020-03-24 Sudhin Biopharma Particle settling devices
CA2976089A1 (en) 2015-02-10 2016-08-18 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
CN104630144B (zh) * 2015-02-13 2018-02-13 中国医科大学 一种脐血间充质干细胞的分离及培养方法
WO2016176288A1 (en) 2015-04-27 2016-11-03 Dana-Farber Cancer Institute, Inc. High throughput bh3 profiling: a rapid and scalable technology to bh3 profile on low numbers of cells
CA3035168A1 (en) * 2015-08-28 2017-03-09 Keith D. Crawford Adult stem cell compositions and methods of identification and isolation
EP3394106A1 (en) * 2015-12-22 2018-10-31 Abbvie Stemcentrx LLC Novel anti-mmp16 antibodies and methods of use
WO2019014486A1 (en) 2017-07-12 2019-01-17 Exosome Diagnostics, Inc. METHODS FOR ISOLATING AND ENRICHING POPULATIONS OF EXTRACELLULAR VESICLES DERIVED FROM BIOFLUIDS, AND METHODS OF USE THEREOF
US10576399B2 (en) 2018-04-18 2020-03-03 Sudhin Biopharma Particle settling devices
KR20220016802A (ko) 2019-02-04 2022-02-10 미네르바 바이오테크놀로지 코포레이션 항-nme 항체 및 암 또는 암 전이의 치료 방법
WO2021188820A1 (en) 2020-03-19 2021-09-23 Sudhin Biopharma Particle settling devices
US12049514B2 (en) 2020-06-08 2024-07-30 Minerva Biotechnologies Corporation Anti-NME antibody and method of treating cancer or cancer metastasis

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
GB9413029D0 (en) * 1994-06-29 1994-08-17 Common Services Agency Stem cell immobilisation
WO1999047674A2 (en) * 1998-03-18 1999-09-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
MXPA02008265A (es) * 2000-02-24 2004-09-10 Xcyte Therapies Inc Concentracion y estimulacion simultanea de calulas.
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
DE60140461D1 (de) * 2000-09-11 2009-12-24 Genzyme Corp Muc1 extrazelluläre domäne und zusammensetzungen für krebsbehandlung, und davon abgeleitete verfahren
WO2005019269A2 (en) 2002-11-27 2005-03-03 Minerva Biotechnologies Corporation Techniques and compositions for the diagnosis and treatment of cancer (muc1)
WO2002056022A2 (en) * 2000-11-27 2002-07-18 Minerva Biotechnologies Corp Diagnostics, drug screening and treatment for cancer
EP1578345A2 (en) * 2001-03-29 2005-09-28 RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. Peptides and antibodies to muc 1 proteins
KR100450578B1 (ko) 2002-03-05 2004-09-30 주식회사 안지오랩 엔엠23 단백질을 유효성분으로 하는, 매트릭스메탈로프로테아제 활성 억제 및 혈관신생 억제용 조성물
US7141369B2 (en) * 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
DE60328492D1 (de) * 2002-05-28 2009-09-03 Panasonic Corp Verfahren zur erzeugung von nanoteilchen
WO2004022590A2 (en) 2002-09-05 2004-03-18 Cell Center Cologne Gmbh Immunogenic muc1 glycopeptides
US20040067585A1 (en) 2002-10-07 2004-04-08 Yu-Chi Wang Cell cultivation surface and method of making the same
US20060173171A1 (en) * 2003-08-26 2006-08-03 Bamdad Cynthia C Techniques and compositions for diagnosis and treatment of cancer (muci)
JP5635726B2 (ja) 2004-09-14 2014-12-03 ミネルバ バイオテクノロジーズ コーポレーション 癌の診断方法及び治療方法
GB0424560D0 (en) * 2004-11-08 2004-12-08 Leuven K U Res & Dev Heart valve tissue engineering
US20060252087A1 (en) * 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
JP2008543276A (ja) * 2005-03-30 2008-12-04 ミネルバ バイオテクノロジーズ コーポレーション Muc1発現細胞の増殖
WO2006108183A2 (en) * 2005-04-05 2006-10-12 Corning Incorporated Label free biosensors and cells
US20090075926A1 (en) 2006-12-06 2009-03-19 Bamdad Cynthia C Method for identifying and manipulating cells
BRPI0806403A2 (pt) * 2007-02-09 2011-09-06 Genentech Inc anticorpo anti-robo4, usode um anticorpo e método de obtenção de imagem
WO2009042814A1 (en) * 2007-09-25 2009-04-02 Minerva Biotechnologies Corp. Early diagnosis and treatment of drug resistance in muc1-positive cancer

Also Published As

Publication number Publication date
US20220252604A1 (en) 2022-08-11
MY157524A (en) 2016-06-15
JP2012529890A (ja) 2012-11-29
US20100316688A1 (en) 2010-12-16
KR20170075023A (ko) 2017-06-30
AU2016204735A1 (en) 2016-07-28
AU2010259858A1 (en) 2012-02-02
KR20210019599A (ko) 2021-02-22
EA201290003A1 (ru) 2012-09-28
EP4043552A1 (en) 2022-08-17
KR20190122749A (ko) 2019-10-30
EP2440652A1 (en) 2012-04-18
US8535944B2 (en) 2013-09-17
EA026732B1 (ru) 2017-05-31
IL216902B (en) 2019-11-28
DOP2011000384A (es) 2012-12-15
WO2010144887A1 (en) 2010-12-16
SG176801A1 (en) 2012-01-30
EP2440652B1 (en) 2019-11-27
AU2016204735B2 (en) 2018-05-17
BRPI1011127A2 (pt) 2017-06-06
EP2440652A4 (en) 2013-05-29
CN102549146A (zh) 2012-07-04
EP3633024A1 (en) 2020-04-08
CN102549146B (zh) 2016-01-13
KR20120025601A (ko) 2012-03-15
CA2767164A1 (en) 2010-12-16
IL216902A0 (en) 2012-02-29
CA2767164C (en) 2019-10-15
US20140044696A1 (en) 2014-02-13
CN104293732A (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
MX2011013385A (es) Metodos para cultivar celulas madre y celulas progenitoras.
IL288185B1 (en) New methods and mediums for growing pluripotent stem cells
EP2438161B1 (en) PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS AND THEIR CULTURE PROCESS
EP2408903A4 (en) PLURIPOTENTE AND MULTIPOTENTE CELL CULTURE ON MICROWAVES
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
EP2373784A4 (en) GENERATION AND MAINTENANCE OF STEM CELLS
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
PH12014501427A1 (en) Anti-php-tau antibodies and their uses
MX349658B (es) Metodo para la diferenciacion de las celulas madre pluripotentes en celulas de lecho vascular.
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
SG195299A1 (en) Expansion of stem cells in hollow fiber bioreactors
IL207083A0 (en) Synthetic surfaces for culturing stem cell derived cardiomyocytes
SG196784A1 (en) Stem cell cultures
EP2671945A4 (en) METHOD OF BREEDING HUMAN PLURIPOTENTER STEM CELLS
EP2784153A4 (en) METHOD FOR THE CULTURE OF PLURIPOTENT STEM CELLS
MX342200B (es) Método de tratamiento de células madre mesenquimales y su uso en el tratamiento de enfermedades asociadas a estrés oxidativo.
MX2014006570A (es) Cocteles de enzimas preparados a partir de cultivos mezclados.
MX2012002019A (es) Sistema de placa de pozos profundos con tapa.
IN2012DN00581A (es)
IN2012DN00852A (es)
MX349801B (es) Sustratos de enzimas de ácido nucleico.
WO2012126013A3 (en) Method for making pluripotent stem cells
EP2559757A4 (en) PROCESS FOR THE PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS
IN2014DN10038A (es)

Legal Events

Date Code Title Description
FG Grant or registration